Neuroscientists demonstrate how the brain improves its ability to distinguish between similar experiences, findings that could lead to treatments for Alzheimer's disease and other memory disorders.
Think of a time when you had two different but similar experiences in a short period. Maybe you attended two holiday parties in the same week or gave two presentations at work. Shortly afterward, you may find yourself confusing the two, but as time goes on that confusion recedes and you are better able to differentiate between these different experiences.
New research published today (January 19) in Nature Neuroscience reveals that this process occurs on a cellular level, findings that are critical to the understanding and treatment of memory disorders, such as Alzheimer's disease.
Dynamic Engrams Store Memories
The research focuses on engrams, which are neuronal cells in the brain that store memory information. "Engrams are the neurons that are reactivated to support memory recall," says Dheeraj S. Roy, PhD, one of the paper's senior authors and an assistant professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. "When engrams are disrupted, you get amnesia."
In the minutes and hours that immediately follow an experience, he explains, the brain needs to consolidate the engram to store it. "We wanted to know: What is happening during this consolidation process? What happens between the time that an engram is formed and when you need to recall that memory later?"
Dheeraj Roy, PhD, assistant professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, is a senior author on a new paper that explains aspects of how memory works at the cellular level. Credit: Sandra Kicman/Jacobs School of Medicine and Biomedical Sciences
The researchers developed a computational model for learning and memory formation that starts with sensory information, which is the stimulus. Once that information gets to the hippocampus, the part of the brain where memories form, different neurons are activated, some of which are excitatory and others that are inhibitory.
When neurons are activated in the hippocampus, not all are going to be firing at once. As memories form, neurons that happen to be activated closely in time become a part of the engram and strengthen their connectivity to support future recall.
"Activation of engram cells during memory recall is not an all or none process but rather typically needs to reach a threshold (i.e., a percentage of the original engram) for efficient recall," Roy explains. "Our model is the first to demonstrate that the engram population is not stable: The number of engram cells that are activated during recall decreases with time, meaning they are dynamic in nature, and so the next critical question was whether this had a behavioral consequence."
Dynamic Engrams Are Needed for Memory Discrimination
"Over the consolidation period after learning, the brain is actively working to separate the two experiences and that's possibly one reason why the numbers of activated engram cells decrease over time for a single memory," he says. "If true, this would explain why memory discrimination gets better as time goes on. It's like your memory of the experience was one big highway initially but over time, over the course of the consolidation period on the order of minutes to hours, your brain divides them into two lanes so you can discriminate between the two."
Roy and the experimentalists on the team now had a testable hypothesis, which they carried out using a well-established behavioral experiment with mice. Mice were briefly exposed to two different boxes that had unique odors and lighting conditions; one was a neutral environment but in the second box, they received a mild foot shock.
A few hours after that experience, the mice, who typically are constantly moving, exhibited fear memory recall by freezing when exposed to either box. "That demonstrated that they couldn't discriminate between the two," Roy says. "But by hour twelve, all of a sudden, they exhibited fear only when they were exposed to the box where they were uncomfortable during their very first experience. They were able to discriminate between the two. The animal is telling us that they know this box is the scary one but five hours earlier they couldn't do that."
Using a light-sensitive technique, the team was able to detect active neurons in the mouse hippocampus as the animal was exploring the boxes. The researchers used this technique to tag active neurons and later measure how many were reactivated by the brain for recall. They also conducted experiments that allowed a single engram cell to be tracked across experiences and time. "So I can tell you literally how one engram cell or a subset of them responded to each environment across time and correlate this to their memory discrimination," explains Roy."
The team's initial computational studies had predicted that the number of engram cells involved in a single memory would decrease over time, and the animal experiments bore that out.
"When the brain learns something for the first time, it doesn't know how many neurons are needed and so on purpose a larger subset of neurons is recruited," he explains. "As the brain stabilizes neurons, consolidating the memory, it cuts away the unnecessary neurons, so fewer are required and in doing so helps separate engrams for different memories."
What Is Happening With Memory Disorders?
The findings have direct relevance to understanding what is going wrong in memory disorders, such as Alzheimer's disease. Roy explains that to develop treatments for such disorders, it is critical to know what is happening during the initial memory formation, consolidation and activation of engrams for recall.
"This research tells us that a very likely candidate for why memory dysfunction occurs is that there is something wrong with the early window after memory formation where engrams must be changing," says Roy.
He is currently studying mouse models of early Alzheimer's disease to find out if engrams are forming but not being correctly stabilized. Now that more is known about how engrams work to form and stabilize memories, researchers can examine which genes are changing in the animal model when the engram population decreases.
"We can look at mouse models and ask, are there specific genes that are altered? And if so, then we finally have something to test, we can modulate the gene for these 'refinement' or 'consolidation' processes of engrams to see if that has a role in improving memory performance," he says.
Reference: "Dynamic and selective engrams emerge with memory consolidation" 19 January 2024, Nature Neuroscience.
DOI: 10.1038/s41593-023-01551-w
News
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]















